esomeprazole 40 mg
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn
Trial Timeline
Nov 1, 2010 โ Jun 1, 2011
NCT ID
NCT01249651About esomeprazole 40 mg
esomeprazole 40 mg is a approved stage product being developed by AstraZeneca for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01249651. Target conditions include Heartburn.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01249651 | Approved | Completed |
| NCT00734097 | Approved | Completed |
Competing Products
20 competing products in Heartburn